Accendra Health (ACH) EBITDA (2016 - 2025)
Historic EBITDA for Accendra Health (ACH) over the last 17 years, with Q3 2025 value amounting to $58.2 million.
- Accendra Health's EBITDA fell 676.16% to $58.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$212.3 million, marking a year-over-year decrease of 21751.25%. This contributed to the annual value of -$207.8 million for FY2024, which is 29880.68% down from last year.
- According to the latest figures from Q3 2025, Accendra Health's EBITDA is $58.2 million, which was down 676.16% from -$7.8 million recorded in Q2 2025.
- In the past 5 years, Accendra Health's EBITDA registered a high of $146.7 million during Q1 2021, and its lowest value of -$262.7 million during Q4 2024.
- In the last 5 years, Accendra Health's EBITDA had a median value of $58.2 million in 2025 and averaged $27.6 million.
- Per our database at Business Quant, Accendra Health's EBITDA skyrocketed by 126381.55% in 2021 and then plummeted by 53774.35% in 2024.
- Over the past 5 years, Accendra Health's EBITDA (Quarter) stood at $62.0 million in 2021, then plummeted by 186.23% to -$53.5 million in 2022, then surged by 212.23% to $60.0 million in 2023, then plummeted by 537.74% to -$262.7 million in 2024, then skyrocketed by 122.14% to $58.2 million in 2025.
- Its last three reported values are $58.2 million in Q3 2025, -$7.8 million for Q2 2025, and $124000.0 during Q1 2025.